4//SEC Filing
Gordon Joseph F 4
Accession 0001127602-21-010164
CIK 0000885590other
Filed
Mar 9, 7:00 PM ET
Accepted
Mar 10, 8:55 PM ET
Size
10.8 KB
Accession
0001127602-21-010164
Insider Transaction Report
Form 4
Gordon Joseph F
President Bausch & Lomb/Int'l
Transactions
- Award
Common Shares, No Par Value
2021-03-08+17,320→ 123,099 total - Exercise/Conversion
Restricted Share Units
2021-03-08−5,637→ 0 totalExp: 2021-03-07→ Common Shares, No Par Value (5,637 underlying) - Exercise/Conversion
Common Shares, No Par Value
2021-03-08+5,637→ 105,779 total - Tax Payment
Common Shares, No Par Value
2021-03-10$32.97/sh−12,461$410,839→ 110,638 total
Footnotes (5)
- [F1]Reflects common shares, no par value ("Common Shares") of Bausch Health Companies Inc. (the "Company") issued to the reporting person following the vesting of, and certification of performance metrics relating to, performance-based Restricted Share Units ("PSUs") granted to the reporting person on March 7, 2018.
- [F2]Each PSU converts into Common Shares on a one-for-one basis.
- [F3]This number represents Common Shares withheld to satisfy the tax withholding obligations due upon vesting of PSUs and RSUs.
- [F4]The PSUs granted to the reporting person on March 7, 2018 were distributed on March 10, 2021 following certification of the achievement of certain performance metrics.
- [F5]This PSU award was previously reported on a Form 3 filed on August 10, 2018 with the target potential award amount of 4,546 shares.
Documents
Issuer
Bausch Health Companies Inc.
CIK 0000885590
Entity typeother
Related Parties
1- filerCIK 0001749876
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 7:00 PM ET
- Accepted
- Mar 10, 8:55 PM ET
- Size
- 10.8 KB